Differential induction of cytochrome P450 isoforms and peroxisomal proliferation by cyfluthrin in male Wistar rats

Toxicology Letters

Volumn 220, Issue 2, 2013, Pages 135-142

  Anadon A ^a   Martinez M A ^a   Martinez M ^a   Castellano, V ^a   Ares, I ^a   Romero, A ^a   Fernandez R ^a   Martinez Larranaga M R ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Antipyrine metabolism; Cyfluthrin; Cytochrome P450 (CYP) enzymes; Peroxisomal enzymes

Indexed keywords

3 HYDROXYMETHYLPHENAZONE; 4 HYDROXYPHENAZONE; CARNITINE ACETYLTRANSFERASE; CYFLUTHRIN; CYTOCHROME P450 1A; CYTOCHROME P450 2E1; CYTOCHROME P450 4A; DRUG METABOLITE; ETHOXYRESORUFIN; LAURIC ACID; NORPHENAZONE; O DEMETHYLASE; PALMITOYL COENZYME A; PHENAZONE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; ENZYME ACTIVITY; FATTY ACID OXIDATION; HYDROXYLATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; URINARY EXCRETION;

ANIMALS; ANTIPYRINE; BEHAVIOR, ANIMAL; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ENZYME INDUCTION; INSECTICIDES; ISOENZYMES; KIDNEY; LIVER; MALE; NITRILES; PEROXISOMES; PYRETHRINS; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 84878984043     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.04.015     Document Type: Article

References (68)

1. Anand S.S., Bruckner J.V., Haines W.T., Muralidhara S., Fisher J.W., Padilla S. Characterization of deltamethrin metabolism by rat plasma and liver microsomes. Toxicology and Applied Pharmacology 2006, 212:156-166.
2. Anadón A., Martínez-Larrañaga M.R., Diaz M.J., Bringas P. Toxicokinetics of permethrin in the rat. Toxicology and Applied Pharmacology 1991, 110:1-8.
3. Anadón A., Martínez-Larranaga M.R., Fernandez-Cruz M.L., Díaz M.J., Fernandez M.C., Martínez M.A. Toxicokinetics of deltamethrin and its 4'-HO-metabolite in the rat. Toxicology and Applied Pharmacology 1996, 141:8-16.
4. Anadón A., Martínez M., Martínez M.A., Díaz M.J., Martínez-Larrañaga M.R. Toxicokinetics of lambda-cyhalothrin in rats. Toxicology Letters 2006, 165:47-56.
5. Balbaa M., Abdelhamid E.M.E., Bassiouny K. Enhancement of lysosomal enzymes by the pyrethroids fenvalerate and trans-cypermethrin. Japanese Journal of Toxicology and Environmental Health 1998, 44:83-91.
6. Behrenz W., Elbert A., Fuchs R. Cyfluthrin (FCR 1272), a new pyrethroid with long-lasting activity for the control of public health and stored-product pests. Pflanzenschutz-Nachrichten Bayer 1983, 36:127-176.
7. Bieber L.L., Abraham T., Helmeath T. A rapid spectrophotometric assay for carnitine palmitoyl transferase. Analytical Biochemistry 1972, 50:509-518.
8. Böttcher J., Bässmann H., Schüppel R. Aromatic ring hydroxylation and sulfatation in antipyrine (phenazone) metabolism of the rat. Biochemistry, Biophysics, Regulation of Cytochrome P450 1980, 981-983. Elsevier North-Holland Biomedical Press, Amsterdam. J.A. Gustafsson, A. Mode, J. Rafter (Eds.).
9. Bronfman M., Inestrona N.C., Leighton F. Fatty acid oxidation by human liver peroxisomes. Biochemical and Biophysical Research Communications 1979.
10. Burke M.D., Thompson S., Elcombe C.R., Halpert J., Hasparanta T., Mayer T.T. Ethoxy-pentoxy- and benzyloxyphenoxasones and homologues. A series of substrates to distinguish between different induced forms of cytochrome P450. Biochemical Pharmacology 1985, 34:3337-3345.
11. Carcillo J.A., Doughty L., Kofos D., Fry R.F., Kaplan S.S., Sasser H., Burchart G.J. Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure. Intensive Care Medicine 2003, 29(6):980-984.
12. Carlson G.P., Schoening G.P. Induction of liver microsomal NADPH cytochrome c reductase and cytochrome P450 by some new synthetic pyrethroids. Toxicology and Applied Pharmacology 1980, 52:507-512.
13. Casida J.E., Gammon D.W., Glickman A.H., Lawrence L.J. Mechanisms of selective action of pyrethroid insecticides. Annual Review of Pharmacology and Toxicology 1983, 23:413-438.
14. Catinot R., Hoellinger H., Sonnier M., Do C.T., Pichon J., Nguyen H.N. In vitro covalent binding of the pyrethroids cismethrin, cypermethrin and deltamethrin to rat liver homogenate and microsomes. Archives of Toxicology 1989, 63:214-220.
15. Crow J.A., Borazjani A., Potter P.M., Ross M.K. Hydrolysis of pyrethroids by human and rat tissues: examination of intestinal, liver and serum carboxylesterases. Toxicology and Applied Pharmacology 2007, 221:1-12.
16. Cummings A.J., Martin B.K., Park G.S. Kinetic considerations relating to the accrual and elimination of drug metabolites. British Journal of Pharmacology and Chemotherapy 1967, 29(2):136-149.
17. Danhof M., de Groot-van der Vis E., Breimer D.D. Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man. Pharmacology 1979, 18:210-223.
18. Danhof M., Krom D.P., Breimer D.D. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcolanthrene treatment. Xenobiotica 1979, 9:695-702.
19. Dayal M., Parmar D., Dhawan A., Ali M., Dwivedi U.N., Seth P.K. Effect of pretreatment of cytochrome P450 (P450) modifiers on neurobehavioral toxicity induced by deltamethrin. Food and Chemical Toxicology 2003, 41:431-437.
20. Deguchi Y., Yamada T., Hirose Y., Nagahori H., Kushida M., Sumida K., Sukata T., Tomigahara Y., Nishioka K., Uwagawa S., Kawamura S., Okuno Y. Mode of action analysis for the synthetic pyrethroid metofluthrin-induced rat liver tumors: evidence for hepatic CYP2B induction and hepatocyte proliferation. Toxicological Sciences 2009, 108(1):69-80.
21. Delescluse C., Ledirac N., de Sousa G., Pralavorio M., Lesca P., Rahmani R. Cytotoxic effects and induction of cytochromes P450 1A1/2 by insecticides, in hepatic or epidermal cells: binding capability to the Ah receptor. Toxicology Letters 1998, 96-97:33-39.
22. Díaz M.J., Chinje E., Kentish P., Jarnot B., George M., Gibson G. Induction of cytochrome P4504A by the peroxisome proliferator perfluoro-n-octanoic acid. Toxicology 1994, 86:109-122.
23. El-Demerdash Lambda-cyhalothrin-induced changes in oxidative stress biomarkers in rabbit erythrocytes and alleviation effect of some antioxidants. Toxicology in Vitro 2007, 21:392-397.
24. Engel G., Hofmann U., Heidemann H., Cosme J., Eichelbaum M. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalizing 4-hydroxyantypirine, 3-hydroxymethylantipyrine, and norantipyrine formation. Clinical Pharmacology and Therapeutics 1996, 59(6):613-623.
25. Eraslan G., Saygi S., Essiz D., Aksoy A., Gul H., Macit E. Evaluation of aspect of some oxidative stress parametrs using vitamin E proanthocyanidin and N-acetylcysteine against exposure to cyfluthrin in mice. Pesticide Biochemistry and Physiology 2007, 88:43-49.
26. European Agency for the Evaluation of Medicinal Products (EMEA), 2000. Cyfluthrin. Summary Report. EMEA/MRL/746/00-FINAL. London, UK.
27. Food and Agricultural Organization of the United Nations (FAO), 1988. Cyfluthrin (Pesticide residues in food: 1987-evaluations. Part II-Toxicology). FAO Plant Production and Protection Paper 78/2, 1988, pp. 756-770.
28. Gibson G.G. Comparative aspects of the mammalian cytochrome P450IVA gen family. Xenobiotica 1989, 19:1123-1148.
29. Gibson G.G. Co-induction of cytochrome P4504A1 and peroxisome proliferation: a causal or causal relationship?. Xenobiotica 1992, 22:1101-1109.
30. Giray B., Gurbay A., Hincal F. Cypermethrin-induced oxidative stress in rat brain and liver is prevented by vitamin E or allopurinol. Toxicology Letters 2001, 118:139-146.
31. Godin S.J., Scollon E.J., Hughes M.F., Potter P.M., DeVito M.J., Ross M.K. Species differences in the in vitro metabolism of deltamethrin and esfenvalerate: differential oxidative and hydrolytic metabolism by humans and rats. Drug Metabolism and Disposition 2006, 34:1764-1771.
32. Godin S.J., Crow J.A., Scollon E.J., Hughes M.F., DeVito M.J., Ross M.K. Identification of rat and human cytochrome P450 isoforms and a rat serum esterase that metabolize the pyrethoid insecticides deltamethrin and esfenvalerate. Drug Metabolism and Disposition 2007, 35:1664-1671.
33. Guengerich F.P., Kim D.H., Iwasaki M. Role of human cytochrome P4502E1 in the oxidation of many low molecular weight cancer suspects. Chemical Research in Toxicology 1991, 4:168-179.
34. Hartleb M. Drugs and the liver. Part II. The role of the antipyrine test in drug metabolism studies. Biopharmaceutics and Drug Disposition 1991, 12:559-570.
35. Heder A.F., Hirsch-Ernst K.I., Bauer D., Kahl G.F., Desel H. Induction of cytochrome P4502B1 by pyrethroids in primary rat hepatocyte cultures. Biochemical Pharmacology 2001, 62:71-79.
36. Imai Y., Ito A., Sato R. Evidence for biochemically different types of vesicles in the hepatic fraction. Journal of Biochemistry 1966, 60:417-428.
37. Inaba T., Lucassen M., Kalow W. Antipyrine metabolism in the rat by three hepatic mono-oxygenases. Life Sciences 1980, 26:1977-1983.
38. Ioannides C., Parke D.V. The cytochrome P450I gene family of microsomal hemoproteins and their role in the metabolic activiation of chemicals. Drug Metabolism Reviews 1990, 22:1-85.
39. Kavlock R., Chernoff N., Baron R., Linder R., Rogers E., Carver B. Toxicity studies with decamethrin, a synthetic pyrethroid insecticide. Journal of Environmental Pathology and Toxicology 1979, 2:751-765.
40. Kitaichi K., Wang L., Takagi K., Iwase M., Shibata E., Nadal M., Takagi K., Hasegawa T. Decreased antipyrine clearance following endotoxin administration: in vivo evidence of the role of nitric oxide. Antimicrobial Agents and Chemotherapy 1999, 43(11):2697-2701.
41. Lock E.A., Mitchell A.M., Elcombe C.R. Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annual Review of Pharmacology and Toxicology 1989, 29:145-163.
42. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein determination with Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
43. Morisseau C., Derbel M., Lane T.R., Stoutamire D., Hammock B.D. Differential induction of hepatic drug-metabolizing enzymes by fenvaleric acid in male rats. Toxicological Sciences 1999, 52:148-153.
44. Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochemical Journal 1953, 55:416-421.
45. Nelson D.R., Kamataki T., Waxman D.J., Guengerich F.P., Estabrook R.W., Feyereisen R., Gonzalez F.J., Coon M.J., Gunsalus I.C., Gotoh O., Okuda K., Nebert D.W. The P450 superfamily Update on new sequences, gene maping, accession numbers, early trivial names of enzymes and nomenclature. DNA and Cell Biology 1993, 12:1-51.
46. Nishi K., Huang H., Kamita S.G., Kim I.H., Morisseau C., Hammock B.D. Characterization of pyrethroid hydrolysis by the human liver carboxylesterases hCE-2. Archives of Biochemistry and Biophysics 2006, 445:115-123.
47. Omura T., Sato R. The carbon monooxide-binding pigment of liver microsomes I: evidence for its hemoprotein nature. Journal of Biological Chemistry 1964, 239:2370-2379.
48. Orton T., Parker G.L. The effect of hypolipidaemic agents on the hepatic microsomal drug-metabolising enzyme in the rat induction of cytochrome (s) P450 with specificity towards terminal hydroxylation of lauric acid. Drug Metabolism and Disposition 1982, 10:110-115.
49. Parker G., Orton T. Induction by oxyisobutyrates of hepatic and kidney microsomal cytochrome P450 with specificity towards hydroxilation of fatty acids. Biochemistry Biophysics and Regulation of Cytochrome P450 1980, 373-377. Elsevier North-Holland Biomedical Press, Amsterdam. J.A. Gustafsson, A. Mode, J. Rafter (Eds.).
50. Poulsen H.E., Loft S. Antipyrine as a model drug to study hepatic drug-metabolizing capacity. Journal of Hepatology 1988, 6:374-382.
51. Reddy J.K., Lalwani N.D. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Critical Reviews in Toxicology 1983, 12:1-58.
52. Reddy J.K., Rao M.S. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis. Mutation Research 1989, 214:63-68.
53. Romero A., Ramos E., Castellano V., Martínez M.A., Ares I., Martínez M., Martínez-Larrañaga M.R., Anadón A. Cytotoxicity induced by deltamethrin and its metabolites in SH-SY5Y cells can be differentially prevented by selected antioxidants. Toxicology in Vitro 2012, 26:823-830.
54. Ruzo L.O., Engel J.L., Casida J.E. Decamethrin metabolites from oxidative, hydrolytic and conjugative reactions in mice. Journal of Agricultural and Food Chemistry 1979, 27:725-731.
55. Sadowska-woda I., Wójcik N., Karowicz-bili'nska A., Bieszczad-bedrejczuk E. Toxicology In Vitro 2010, 24:879-884.
56. Scollon E.J., Starr J.M., Godin S.J., DeVito M.J., Hughes M.F. In vitro metabolism of pyrethroid pesticides by rat and human hepatic microsomes and cytochrome P450 isoforms. Drug Metabolism and Disposition 2009, 37:221-228.
57. Sharma R.K., Doig M.V., Lewis D.F., Gibson G.G. Role of hepatic and renal cytochrome P-450IVA1 in the metabolism of lipid substrates. Biochemical Pharmacology 1989, 38:3621-3629.
58. Sharma R.K., Lake B.G., Makowski R., Bradshaw T., Earnshaw D., Dale J.W., Gibson G.G. Differential induction of peroxisomal and microsomal fatty acid oxidising enzymes by peroxisome proliferators in rat liver and kidney Characterization of renal cytochrome P450 and implications for peroxisome proliferation. European Journal of Biochemistry 1989, 184:69-78.
59. Shono T., Ohsawa K., Casida J.E. Metabolism of trans- and cis-permethrin, trans- and cis-cypermethrin, and decamethrin by microsomal enzymes. Journal of Agricultural and Food Chemistry 1979, 27:315-325.
60. Soderlund D.M., Clark J.M., Sheets L.P., Mullin L.S., Piccirillo V.J., Sargent D., Stevens J.T., Weiner M.L. Mechanisms of pyrethroid neurotoxicity: implications for cumulative risk assessment. Toxicology 2002, 171:3-59.
61. Suberg, H., Loser, E., 1983. FCR 1272 (cyfluthrin). Chronic toxicity study on rats (2-year feeding experiment). Unpublished Report No. 11949 from Bayer Institute of Toxicology,'submitted to WHO by Bayer AG, Leverkusen, FRG.
62. Tamburini P.P., Masson H., Bains S.K., Makowski R., Morris B.A., Gibson G.G. Multiple forms of hepatic cytochrome P450. Purification, characterisation and comparison of a novel clofibrate induced isoenzyme with other major forms of cytochrome P450. European Journal of Biochemistry 1984, 139:235-246.
63. Van Der Graaff M., Vermeulen N.P.E., Joeres R.P., Vlietstra T., Breimer D.D. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats. Journal of Pharmacology and Experimental Therapeutics 1983, 227:459-465.
64. Vences-Mejía A., Gomez-Garduño J., Caballero-Ortega H., Dorado-Gonzalez V., Nosti-Palacios R., Labra-Ruiz N., Espinosa-Aguirre J.J. Effect of mosquito mats (pyrethroid-based) vapor inhalation on rat brain cytochrome P450s. Toxicology Mechanisms and Methods 2012, 22(1):41-46.
65. Wrighton S.A., Maurel P., Schultz E.G., Watkins P.B., Young B., Guzelian P.S. Identification of the cytochrome P-450 induced by macrolide antibiotics in the rat liver as the glucocorticoid responsive cytochrome P-450. Biochemistry 1985, 24:2171-2178.
66. Yamaoka K., Nakagawa T., Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics 1978, 6:165-175.
67. Yang D., Wang X., Chen Y., Deng R., Yan B. Pyrethroid insecticides: isoform-dependent hydrolysis induction of cytochrome P450 3A4 and evidence on the involvement of the pregnance X receptor. Toxicology and Applied Pharmacology 2009, 45:497-504.
68. Zaar K., Volkl A., Fahimi H.D. Association of isolated bovine kidney cortex peroxisomes with endoplasmic reticulum. Biochimica et Biophysica Acta 1987, 237:49-58.